Neuralink Expands Brain Chip Trial to UK

Neuralink, Elon Musk's brain-computer interface startup, has announced the launch of a new feasibility study named 'CONVOY' to test its N1 brain implant's ability to control a robotic arm, focusing on restoring autonomy for people with disabilities such as quadriplegia. The study aims to build on the success of previous trials where patients used the implant to control digital devices, like playing video games and moving a cursor. Neuralink has already implanted the device in two patients, and the new trial will cross-enroll participants from its ongoing PRIME study. The company has expanded its testing to Canada and the UK, following approval from Health Canada. The trial represents an essential step towards enabling physical freedom for patients, and the implanted chip translates brain signals into Bluetooth commands to control external devices, offering new possibilities for assistive technologies.